IceCure Medical Ltd. ICCM
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $3.38M, +2.7% YoY · Filed Mar 17, 2026
IceCure Medical Ltd. (ICCM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.4 million and a net loss of $15.1 million. Free cash flow was -$14.6 million. As of Dec 31, 2025 it held $8.9 million in cash and investments and $230,000 in total debt.
Revenue
$3.38M
+2.7% vs prior year
Net income
$-15.06M
+1.7% vs prior year
Operating cash flow
$-14.57M
-16.0% vs prior year
Free cash flow
$-14.61M
-15.6% vs prior year
EPS
$0.24
-20.0% vs prior year
Dividend per share
None
Shares outstanding
73.12M
+29.3% vs prior year
Net cash
$8.67M
FY 2025
Operating margin
-446.7%
FY 2025
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- ICCM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Caesarea
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1584371
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.4M | $3.3M | $3.2M | $3.1M | $4.1M |
| Operating income | -$15.1M | -$15.7M | -$15.6M | -$16.7M | -$9.7M |
| Net income | -$15.1M | -$15.3M | -$14.7M | -$17.0M | -$9.9M |
| Diluted EPS | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 |
| Operating cash flow | -$14.6M | -$12.6M | -$12.6M | -$14.3M | -$12.6M |
| Free cash flow | -$14.6M | -$12.6M | -$13.0M | -$15.2M | -$13.1M |
| Total assets | $13.9M | $12.6M | $16.4M | $30.2M | $32.3M |
| Stockholders' equity | $9.1M | $6.9M | $12.2M | $25.4M | $27.0M |
| Cash and investments | $8.9M | $7.6M | $11.1M | $23.7M | $25.6M |
| Total debt | $230,000 | $459,000 | $599,000 | $597,000 | $909,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Oct 13, 2026 | Oct 13, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 28, 2026 | Sep 28, 2026 |
All 319 IceCure Medical Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.